Chronic News and Research

RSS

Cox Enterprises makes investment in Atlanta-based Rimidi

Cox Enterprises announced today an investment in Atlanta-based Rimidi, a digital health company focused on diabetes and other chronic conditions. This marks a major milestone for the company, paving the way for Rimidi's expansion into additional markets and collaborative opportunities.

29 Apr 2015

Sangamo BioSciences to present data on ZFP Therapeutic platform at ASGCT meeting

Sangamo BioSciences, Inc. announced that data from clinical, preclinical and research-stage programs focused on the development of ZFP Therapeutics will be presented at the 18th Annual Meeting of the American Society of Gene and Cell Therapy

29 Apr 2015

Global market for cardiac rhythm management devices worth $13 billion for 2015

The global market for cardiac rhythm management devices such as pacemakers and defibrillators is worth about $13 billion for 2015, according to Kalorama Information. The market research publisher said the market has benefited from the demand to move to a more mobile, wireless and efficient system both within major health facilities and in the home treatment markets. There is also an increasing trend to upgrade to more portable devices and devices which have added benefits such as MRI compatibility.

29 Apr 2015

Researchers describe critical connection associated with environmental cause of silicosis, lung cancer

Researchers at the University of Louisville have detailed a critical connection associated with a major environmental cause of silicosis and a form of lung cancer. Their study is reported in today's Nature Communications.

29 Apr 2015

Scripps Florida scientists uncover surprising new details of potential alzheimer’s treatment

The new study points to promising new directions using a known therapeutic strategy for Alzheimer’s disease—a disorder that will affect nearly 14 million Americans by 2050, according to the Alzheimer’s Association...

29 Apr 2015

New TSRI study points to promising new therapeutic target for Alzheimer's disease

Taking a new approach, scientists from the Florida campus of The Scripps Research Institute (TSRI) have uncovered some surprising details of a group of compounds that have shown significant potential in stimulating the growth of brain cells and memory restoration in animal models that mimic Alzheimer's disease.

29 Apr 2015

Researchers say that lack of safety at school, poverty associated with childhood obesity

A lack of safety at school is one of the correlates of childhood obesity, say researchers at the University of Montreal and its affiliated Research Centre at CHU Sainte Justine children's hospital.

29 Apr 2015

Only few sexually assaulted servicewomen seek post-assault health care, study finds

Despite growing public awareness of sexual assault of women during their military service and increased efforts by the Department of Defense to deter sexual crimes and encourage reporting and help-seeking, a Veterans Affairs study suggests most female service members who experience sexual assault are still unlikely to seek post-assault health care, at least in the short term.

29 Apr 2015

New genetic mutation appears to protect people from Type 2 diabetes

An international team of scientists led by a Cedars-Sinai researcher has identified a new genetic mutation that appears to protect people from developing Type 2 diabetes.

29 Apr 2015

Emergency department-initiated treatment better than referrals for opioid-dependent patients

Yale researchers conducted the first known randomized trial comparing three treatment strategies for opioid-dependent patients receiving emergency care. They found that patients given the medication buprenorphine were more likely to engage in addiction treatment and reduce their illicit opioid use.

29 Apr 2015

Imprimis has exclusive US commercial rights for patented Hep-Lido-A formulation

Imprimis Pharmaceuticals, Inc., a pharmaceutical company focused on the development and commercialization of proprietary compounded drug formulations, today announced it now has the exclusive US commercial rights to the patented compounded alkalinized lidocaine and heparin formulation ("Hep-Lido-A" or "HLA") for the treatment of interstitial cystitis ("IC"), commonly referred to as painful bladder syndrome ("PBS").

28 Apr 2015

High-dose flu vaccine more effective than standard dose for elders

If you're age 65 or older and go to your doctor or pharmacy for a flu shot, you may be offered two options: the standard vaccine, or a high-dose version that packs a stronger wallop to activate the immune system, which is weaker in seniors. The Centers for Disease Control and Prevention (CDC) says either vaccine is appropriate for this age group.

28 Apr 2015

Teen-LABS research study reveals musculoskeletal disease outcomes among obese adolescents

Outcomes regarding musculoskeletal disease among severely obese adolescents participating in the "Teen Longitudinal Assessment of Bariatric Surgery" (Teen-LABS) study were published this week in JAMA Pediatrics. Teen-LABS is a multi-center clinical study funded by the National Institute of Diabetes and Digestive and Kidney Diseases at the National Institutes of Health that is examining the safety and health effects of surgical weight loss procedures.

28 Apr 2015

Mount Sinai, par8o create referral platform for Health System's care providers

The Mount Sinai Health System and software company par8o are creating a seamless referral process for the Health System's care providers.

28 Apr 2015

Gas naturally produced within our bodies reduces severity of RSV infection, UTMB study finds

A new study from the University of Texas Medical Branch at Galveston is the first to show that hydrogen sulfide, a gas produced naturally within our bodies, reduces the severity of respiratory syncytial virus, or RSV.

28 Apr 2015

New T1D Prevention Initiative launched to identify pathways to prevent type 1 diabetes

As the incidence of type 1 diabetes (T1D) rises worldwide, The Leona M. and Harry B. Helmsley Charitable Trust today announced the launch of an ambitious new T1D Prevention Initiative to investigate the early stages of development of the disease and identify new pathways to prevent it.

28 Apr 2015

Study suggests that inhibiting FOXO1 protein could speed diabetic wound healing

A protein that normally fosters tissue repair instead acts to inhibit healing when sugar levels are high, according to a study in The Journal of Cell Biology. The role reversal helps explain why wounds heal slowly in people with diabetes.

28 Apr 2015

MiMedx Group's revenue increases 108% to $40.8 million in first quarter 2015

MiMedx Group, Inc., the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic and Dental sectors of healthcare, announced today its record results for the first quarter of 2015.

28 Apr 2015

Intarcia Therapeutics announces closing of $225 million synthetic royalty financing

Intarcia Therapeutics, Inc. today announced the closing of a $225 million synthetic royalty financing with an equity conversion option at a $5.5 billion Company valuation. Plans are to use these funds to accelerate the initiation of additional head-to-head comparative and switch studies of ITCA 650 vs. leading oral and injectable type 2 diabetes therapies.

28 Apr 2015

New Cannabis and Cannabinoid Research journal to be launched in fall 2015

Cannabis and Cannabinoid Research, a new peer-reviewed, open access journal from Mary Ann Liebert, Inc., publishers, is the only journal dedicated to the scientific, medical, and psychosocial exploration of clinical cannabis, cannabinoids, and the biochemical mechanisms of endocannabinoids.

25 Apr 2015

Chronic News and Research

Cox Enterprises makes investment in Atlanta-based Rimidi

Sangamo BioSciences to present data on ZFP Therapeutic platform at ASGCT meeting

Global market for cardiac rhythm management devices worth $13 billion for 2015

Researchers describe critical connection associated with environmental cause of silicosis, lung cancer

Scripps Florida scientists uncover surprising new details of potential alzheimer’s treatment

New TSRI study points to promising new therapeutic target for Alzheimer's disease

Researchers say that lack of safety at school, poverty associated with childhood obesity

Only few sexually assaulted servicewomen seek post-assault health care, study finds

New genetic mutation appears to protect people from Type 2 diabetes

Emergency department-initiated treatment better than referrals for opioid-dependent patients

Imprimis has exclusive US commercial rights for patented Hep-Lido-A formulation

High-dose flu vaccine more effective than standard dose for elders

Teen-LABS research study reveals musculoskeletal disease outcomes among obese adolescents

Mount Sinai, par8o create referral platform for Health System's care providers

Gas naturally produced within our bodies reduces severity of RSV infection, UTMB study finds

New T1D Prevention Initiative launched to identify pathways to prevent type 1 diabetes

Study suggests that inhibiting FOXO1 protein could speed diabetic wound healing

MiMedx Group's revenue increases 108% to $40.8 million in first quarter 2015

Intarcia Therapeutics announces closing of $225 million synthetic royalty financing

New Cannabis and Cannabinoid Research journal to be launched in fall 2015

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News